With 23andme in a desperate situation and eyeing a potential sale, Medical Device Network examines what is set to happen to ...

Once the domain of science fiction, neurotechnology is a reality with enormous implications for medicine and the digital ...

A huge data breach followed by a plummeting valuation has stoked fears of a sale of 23andMe along with all of its customers' genetic data.

Yang Liu of Atlantis Investment Management discusses factors creating momentum in Chinese equities, expecting the market to ...

Gray’s optimism on IPO markets provided a positive gloss to its muted asset sales in third-quarter results released on Thursday. The biggest story at Blackstone is its continued growth in almost any ...

A big data breach and deepening financial woes have sparked new concerns about the DNA testing company's ability to protect ...

In 2023, 23andMe had a data breach the exposed millions of people ancestry data. The lawsuit that followed, has reached a $30 ...

Following its 2023 data breach, a new $30 million settlement by 23andMe may offer victims up to $10,000 in compensation.

Me agreed to pay $30 million and provide three years of security monitoring to settle a lawsuit accusing the genetics testing ...

Ancestry company 23andMe agreed to settle a multi-million class action lawsuit that accused it of not protecting its users’ ...

23andMe, named because of the number of chromosome pairs in human DNA, raised more than $1.1bn before its hotly awaited IPO ...

Bodai opened on Tuesday, October 15, offering a multicourse plant-based chinese menu by Master Chef Guo Wenjun. Hidden on the ...